Recent Finacing
Recent Raise
i2O Therapeutics develops an oral-delivery platform using ionic-liquid formulations and enteric coatings to protect and release peptides, proteins, and large-molecule biologics (e.g., GLP‑1 analogs) in the small intestine.
